Viglinskaia I V, Seredenin S B, Kolik L G
Laboratory of Pharmacogenetics, Russian Academy of Medical Sciences, Moscow, Russia.
Eksp Klin Farmakol. 2000 May-Jun;63(3):52-4.
Dynamics of the alcohol intake variation in MR and MNRA inbred rats with different emotional-stress reaction (ESR) phenotypes was studied in the course of a 7-month voluntary alcoholization. Initially, the MNRA rats with an active ESR phenotype showed a higher level of a 15% aqueous ethanol consumption than did the MR rats. After 3 months, the consumption of ethanol in the highly emotional MR rats sharply increased and was retained on a high level during subsequent alcoholization. The new anxiolytic agent afobazol [5-ethoxy-2(morpholinoethylthio)-benzimidazole hydrochliride] did not potentiate the CNS depressant action of alcohol. A 2-week administration of afobazol (1 mg/kg, i.p.) after a 6-month alcoholization markedly reduced the alcohol consumption and reduced the craving to alcohol in the rats of both lines studied.
在7个月的自愿酒精化过程中,研究了具有不同情绪应激反应(ESR)表型的MR和MNRA近交系大鼠酒精摄入量变化的动态情况。最初,具有活跃ESR表型的MNRA大鼠对15%乙醇水溶液的消耗量高于MR大鼠。3个月后,情绪高度敏感的MR大鼠的乙醇消耗量急剧增加,并在随后的酒精化过程中保持在高水平。新型抗焦虑药物阿福唑(5-乙氧基-2-(吗啉代乙硫基)-苯并咪唑盐酸盐)不会增强酒精对中枢神经系统的抑制作用。在6个月酒精化后,连续2周给予阿福唑(1mg/kg,腹腔注射)可显著降低两个品系大鼠的酒精消耗量,并减少对酒精的渴望。